Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Seer Inc SEER

Technology Scientific & Technical Instruments
Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution... see more

Recent & Breaking News (NDAQ:SEER)

DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS

PR Newswire December 14, 2022

Seer's Proteomics Platform Named as Top 10 Innovation in 2022 by The Scientist

GlobeNewswire December 12, 2022

Seer Reports Third Quarter 2022 Financial Results

GlobeNewswire November 8, 2022

Seer to Report Third Quarter 2022 Financial Results on November 8, 2022

GlobeNewswire October 13, 2022

Seer to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire August 30, 2022

Seer Announces Publication of Seminal Study Demonstrating the Power of Engineered Nano-Bio Interactions to Enable Deep Access to the Proteome

GlobeNewswire August 23, 2022

Seer Reports Second Quarter 2022 Financial Results

GlobeNewswire August 9, 2022

Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph(TM) Analysis Suite 2.0

GlobeNewswire August 3, 2022

Seer to Report Second Quarter 2022 Financial Results on August 9, 2022

GlobeNewswire July 14, 2022

Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)

GlobeNewswire May 24, 2022

Seer Reports First Quarter 2022 Financial Results

GlobeNewswire May 4, 2022

Seer to Present at the BofA Securities 2022 Healthcare Conference

GlobeNewswire April 28, 2022

Seer to Report First Quarter Financial Results on May 4, 2022

GlobeNewswire April 7, 2022

ROSEN, A LEADING LAW FIRM, Encourages Seer, Inc. Investors With Losses to Inquire About Class Action Investigation - SEER

PR Newswire April 5, 2022

SEER SHAREHOLDER ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Seer, Inc. Investors with Losses to Inquire About Class Action Investigation - SEER

Newsfile April 1, 2022

Seer Announces Appointment of Scott D. Thomas as Chief Commercial Officer

GlobeNewswire March 16, 2022

Seer Announces Publication of Seminal Study Demonstrating Superior Performance of Technology Platform for Deep, Unbiased, Precise, Scalable Proteomics in the Proceedings of the National Academy of Sciences

GlobeNewswire March 14, 2022

Seer Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Outlook

GlobeNewswire February 28, 2022

Seer to Present at the Cowen 42nd Annual Health Care Conference

GlobeNewswire February 22, 2022

Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021

GlobeNewswire February 1, 2022